Unknown

Dataset Information

0

Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.


ABSTRACT: Tissue transglutaminase (TG2) is a multifunctional protein with enzymatic, GTP-ase, and scaffold properties. TG2 interacts with fibronectin (FN) through its N-terminus domain, stabilizing integrin complexes, which regulate cell adhesion to the matrix. Through this mechanism, TG2 participates in key steps involved in metastasis in ovarian and other cancers. High-throughput screening identified several small molecule inhibitors (SMI) for the TG2/FN complex. Rational medicinal chemistry optimization of the hit compound (TG53) led to second-generation analogues (MT1-6). ELISA demonstrated that these analogues blocked TG2/FN interaction, and bio-layer interferometry (BLI) showed that the SMIs bound to TG2. The compounds also potently inhibited cancer cell adhesion to FN and decreased outside-in signaling mediated through the focal adhesion kinase. Blockade of TG2/FN interaction by the small molecules caused membrane ruffling, delaying the formation of stable focal contacts and mature adhesions points and disrupted organization of the actin cytoskeleton. In an in vivo model measuring intraperitoneal dissemination, MT4 and MT6 inhibited the adhesion of ovarian cancer cells to the peritoneum. Pretreatment with MT4 also sensitized ovarian cancer cells to paclitaxel. The data support continued optimization of the new class of SMIs that block the TG2/FN complex at the interface between cancer cells and the tumor niche.

SUBMITTER: Sima LE 

PROVIDER: S-EPMC6548576 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.

Sima Livia Elena LE   Yakubov Bakhtiyor B   Zhang Sheng S   Condello Salvatore S   Grigorescu Arabela A AA   Nwani Nkechiyere G NG   Chen Lan L   Schiltz Gary E GE   Arvanitis Constandina C   Zhang Zhong-Yin ZY   Matei Daniela D  

Molecular cancer therapeutics 20190423 6


Tissue transglutaminase (TG2) is a multifunctional protein with enzymatic, GTP-ase, and scaffold properties. TG2 interacts with fibronectin (FN) through its N-terminus domain, stabilizing integrin complexes, which regulate cell adhesion to the matrix. Through this mechanism, TG2 participates in key steps involved in metastasis in ovarian and other cancers. High-throughput screening identified several small molecule inhibitors (SMI) for the TG2/FN complex. Rational medicinal chemistry optimizatio  ...[more]

Similar Datasets

| S-EPMC3930694 | biostudies-literature
| S-EPMC4858652 | biostudies-literature
| S-EPMC4121214 | biostudies-literature
| S-EPMC7905945 | biostudies-literature
| S-EPMC3365763 | biostudies-literature
| S-EPMC3174992 | biostudies-literature
| S-EPMC5269585 | biostudies-literature
| S-EPMC3064359 | biostudies-literature
| S-EPMC4592394 | biostudies-literature
| S-EPMC6176332 | biostudies-literature